Suraksha Diagnostics IPO: What Investors Can Expect from the Listing

"Suraksha Diagnostics, which primarily offers pathology and radiology services with a revenue focus in West Bengal, is preparing for its stock market listing. The IPO saw moderate interest, being subscribed 1.27 times and fully subscribed on the last day. With a grey market premium (GMP) of ₹13 (around 2.95%), it suggests a potential listing gain of 2-3%, according to Shivani Nyati, Head of Wealth at Swastika Investmart Ltd."